Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK
TRESK is a two-pore domain potassium channel. Loss of function mutations have been linked to typical migraine with aura and due to TRESK's expression pattern and role in neuronal excitability it represents a promising therapeutic target. We developed a cell based assay using baculovirus transdu...
Main Authors: | Wright, P, Weir, G, Cartland, J, Tickle, D, Kettleborough, C, Cader, M, Jerman, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK.
by: Wright, P, et al.
Published: (2013) -
Cloxyquin activates hTRESK by allosteric modulation of the selectivity filter
by: Julian Alexander Schreiber, et al.
Published: (2023-07-01) -
High-fat diet–induced vagal afferent dysfunction via upregulation of 2-pore domain potassium TRESK channel
by: Gintautas Grabauskas, et al.
Published: (2023-02-01) -
TRESK background potassium channel is not gated at the helix bundle crossing near the cytoplasmic end of the pore.
by: Miklós Lengyel, et al.
Published: (2018-01-01) -
A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura.
by: Lafrenière, R, et al.
Published: (2010)